0.21 USD
▼+0.01-1.04%
2026-08-03
市值
$5.95M
市盈率
—
EPS
-0.27
股息率
—
52 周区间
0.18 – 9.18
成交量
162.75K
Beta
—
目标价
—
52W 低 0.1852W 高 9.18
价格走势
公司简介
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New ...